Flora Growth Corp.

FLGC • Drug Manufacturers - Specialty & Generic

$8.88

— 0.00 (0.00%)

EarningsLatest report: Mar 31, 2026

HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.

Market Cap

$88.43M

Growth

—

Cash Flow

0/5

Trend

Negative

Evidence

Positive revenue growth · 21.0%Manageable debt level · 0.76Weak profitability

Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Mar 31, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$8.88

Change0.00%

Shares Out9.96M

Market Cap$88.43M

Enterprise Value$90.00M

52W Range5.86 - 47.00

Beta1.90

P/E-0.57

P/S2.15

P/B2.40

P/FCF-8.59

EV/Sales2.19

Price$8.88

Change0.00%

Shares Out9.96M

Market Cap$88.43M

Enterprise Value$90.00M

52W Range5.86 - 47.00

Beta1.90

P/E-0.57

P/S2.15

P/B2.40

P/FCF-8.59

EV/Sales2.19

EV/EBITDA-8.09

EV/FCF-8.74

Earnings Yield-176.00%

FCF Yield-11.65%

Dividend Yield0.00%

Gross Margin43.35%

Oper. Margin-30.74%

Profit Margin-30.52%

Debt/Eq0.76

Current Ratio1.01

Quick Ratio0.79

Target$185.00

Target Upside1983.33%

Target Median$185.00

Target Range30.00 - 340.00

Volume107.94K

Avg Volume96.64K

EPS Surprise-2.80

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

22/100

Financial Strength

Debt, cash, stability

45/100

Growth Potential

Revenue and expansion

95/100

Price Attractiveness

Cheap or expensive today

50/100

Why this score▼

Positive revenue growth · 21.0%Manageable debt level · 0.76Weak profitability

Analyst view

Analyst sentiment and price target

FLGC

Analyst sentiment

Based on 6 analyst votes · 2026-10-20

83/100

Bullish

Hold

Bearish

Price Target

2026-06-19

Low

$30.00

Mean

$185.00

Median

$185.00

High

$340.00

Company Overview

IPO: 5/11/2021

Industry: Drug Manufacturers - Specialty & Generic

P/B i: 2.40

Debt / Equity i: 0.76

Operating Margin: -30.74%

Net Margin: -30.52%

ROE i: -

ROIC: -

Financial Health

Score9 / 20

Debt / Equity: 0.76

Current Ratio: 1.01

Quick Ratio: 0.79

Status: Moderate

🧾

No insider activity

No recent insider transactions available.

About the Company

Flora Growth Corp.

Flora Growth Corp., along with its various subsidiaries, operates as a global enterprise specializing in the cultivation, processing, and advancement of medicinal cannabis and its derived products. The company distributes these offerings to a broad international client base, including pharmacies, medical clinics, and cosmetic companies. Its extensive portfolio encompasses a range of activities and products: Cannabis and Derivatives: This core segment involves the production and supply of medical-grade cannabis oil, alongside a spectrum of cannabis-infused medical and wellness items. Health and Personal Care: They develop and market skincare and beauty products, plant-based pharmaceuticals, phytotherapeutics, and dietary supplements. Furthermore, their offerings include a wide array of cannabidiol (CBD) products like edibles (gummies), topical applications, tinctures, and vaping solutions, as well as general lifestyle wellness items such as bath and body products, pet care, and sports recovery aids. Ancillary and Lifestyle Products: Flora Growth designs and sells loungewear crafted from hemp-derived fabrics and provides accessories for cannabis consumption, personal storage, and travel, catering to both vape and dry herb users. Food and Beverages: The company's diversified operations also include the distribution of juices, gourmet chocolates (featuring exotic fruits coated in chocolate and chocolate bars), and dried fruits, beans, and pulp sourced from Amazonian regions. These items reach consumers through various retail channels, including supermarkets, discount stores, coffee shops, restaurants, and airports. They also manufacture, promote, and distribute other beverage products. Pharmaceutical Initiatives: Flora Growth is involved in creating and distributing pain relief formulations and is actively pursuing the development of a pharmaceutical cannabinoid formula intended for Sars-Cov-2 prevention. Their products are marketed under several distinct brands, including JustCBD, Vessel, Mind Naturals, Mambe, Stardog, Tonino Lamborghini, and Kalaya. Established in 2019, Flora Growth Corp. maintains its corporate headquarters in Toronto, Canada.

Source - link

Peers

AIM AKAN AMIX CPHI ENSC KALA KZIA MYNZ OGEN RDHL

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

📰

No news available now

Check back later.

Earnings Surprises

Period	Estimate	Actual	Surprise
2025-11-05	-2.13	-4.93	-2.8
2025-08-01	-2.34	-4.3	-1.96
2025-05-13	-0.39	-1.56	-1.17
2025-03-24	-0.11	-16.41	-16.3
2024-11-13	-3.52	-9.38	-5.86
2024-08-12	-1.95	-8.59	-6.64
2024-05-14	-8.59	-10.94	-2.35
2024-03-29	-0.07	-0.17	-0.1
2023-11-08	-7.81	-1.95	5.86
2023-08-10	-15.63	-12.11	3.52
2023-05-15	-31.25	-23.44	7.81
2023-03-31	-70.31	-117.19	-46.88